Martin Shkreli, the former pharmaceutical executive who gained notoriety for hiking up the price of a life-saving drug, will finally go on trial next week on charges of ripping off investors.
Shkreli sparked outrage in 2015 for increasing the price of Daraprim, a drug used by AIDS patients, by more than 5,000% from $13.50 to $750 a pill while he was CEO of Turing Pharmaceuticals.
James and Carrie Finan have been house-hunting in the Seattle area for four months in a seemingly futile race against time: Theyre living in a room in James mothers house and their first child is due in September.
Theyve seen about 40 starterhouses that match their criteria$350,000 or less, three bedrooms, about 1,200 square feet — and made four offers ranging from $32,000 to $82,000....More>>>
5 Ways Washington Is Choking Your Annuity Business
3 Reasons DOL Fiduciary Rule Will Stay Intact: ERISA Attorney Wagner
Victor Fetter Is Out at LPL; Former AmEx, eBay Exec Is In
For the first time in three years, rising college costs will reflect not only the increase in tuition and fees but also higher interest rates on student loans. Beginning this academic year, rates on....More>>>
My True Wealth subscribers just pocketed 19% in two months – in boring Treasury bonds. How did they do it? Today, I'll share with you exactly what we did. It's a perfect teaching moment for how to set up a trade, when to get in, and when to get out… The entire trade took place over three issues of my True Wealth newsletter… 1. ....More>>>
Image source: Palo Alto Networks.
Palo Alto Networks (NYSE:PANW) will look for redemption when it releases its second-quarter fiscal 2017 results after the bell on Feb. 28. The network security specialist had offered a weaker-than-expected outlook in its last quarterly report as some of its deals requiring “additional approvals” got pushed back.
Data by YCharts.
March 10, 2017: Here are four stocks trading with relatively heavy volume among 85 equities making new 52-week lows in Friday’s session. On the NYSE, advancers led decliners by nearly 2 to 1 and on the Nasdaq advancers led by decliners about 4 to 3.
Sally Beauty Holdings Inc. (NYSE: SBH) posted a new 52-week low of $20.22 on Friday, down 0.3% compared with Thursday’s closing price....More>>>
President and CEO of Granite Point Mortgage Trust Inc (NYSE:GPMT) John A Taylor bought 50,000 shares of GPMT on 06/28/2017 at an average price of $19.5 a share. The total cost of this purchase was $975,000.
Granite Point Mortgage Trust Inc has a market cap of $817.970 million; its shares were traded at around $18.92 with a P/E ratio of 85.88.
CEO Recent Trades:
Stocks edged higher today despite Donald Trump trashing the health care sector in his press conference today.
The S&P 500 rose 0.3% to 2,275.32 today, while the Dow Jones Industrial Average gained 98.75 points, or 0.5%, to 19,954.28. The Nasdaq Composite advanced 0.2% to5,563.65–and hit its fifth consecutive high–despite the fact that biotech stocks tumbled....More>>>
A few weeks ago, we published an article that characterized Gilead (GILD) as a “Value Trap.” That article was a follow-up to an earlier article which used our work on Gilead as an example of how a solid conceptual framework could help investors make better decisions. Both of these articles were based on a 16-page valuation report on Gilead we published to our members in September, 2016.
The humanization of pets and the increased and impulsive spending that goes along with that has been a trend for many years now.
A number of stocks have seen huge benefits including pharmaceutical related plays, veterinary supplies, food manufacturers, and more.
IDEXX Laboratories (NASDAQ:IDXX) produces diagnostic solutions for animal care and IT solutions for vets.